4th Advanced ECCO: EduCational COurse for Industry

Date
March 6, 2019
Time 
Wednesday, March 6 from 14:00 to 18:00  
Organisation
ClinCom
Target audience 
Corporate Members & Non-corporate Members
Registration
Please contact the ECCO Office at This email address is being protected from spambots. You need JavaScript enabled to view it. to register for this course
ECCO Membership
N/A
Registration fee
Non-Corporate Members: EUR 600.- incl. 25% Danish VAT
Corporate Members: EUR 400.- incl. 25% Danish VAT
Kindly direct any question or further clarification to the ECCO Office at This email address is being protected from spambots. You need JavaScript enabled to view it. 

  • 4th Advanced ECCO: EduCational COurse for Industry
    (As of November 2018)
    14:00-14:05 1: Welcome & Introduction
    Silvio Danese, Milan, Italy
    14:05-14:55 2: Session 1: Individualized therapy: The role of prognostic biomarkers
    Shomron Ben-Horin, Ramat Gan, Israel

    Panel discussion and interaction with the audience:
    Shomron Ben-Horin, Ramat Gan, Israel
    Silvio Danese, Milan, Italy
    Brihad Abhyankar, Dublin, Ireland (Theravance)
    Mark Ainsworth, Copenhagen, Denmark (Danish Medicines Agency)
    Swati Tole, San Francisco, United States (Roche)

    14:55-15:45 3: Session 2: From phase 3 to first-line use
    Laurent Peyrin-Biroulet, Vandœuvre-lès-Nancy, France

    Panel discussion and interaction with the audience:
    Brian Feagan, London, Canada 
    Laurent Peyrin-Biroulet, Vandœuvre-lès-Nancy, France

    Fabio Cataldi, Cambridge, United States (AbbVie)
    Scott Plevy, Spring House, United States (Johnson & Johnson)
    Elmer Schabel, Bonn, Germany (Bundesintitut für Arzneimittel und Medizinprodukte)
    15:45-16:15 Coffee break
    16:15-17:05 4: Session 3: Challenges in paediatric study design
    Anne Griffiths, Toronto, Canada

    Panel discussion and interaction with the audience:
    Lissy de Ridder, RotterdamThe Netherlands
    Anne Griffiths, Toronto, Canada

    Laurence D’Agay, Boudry, Switzerland (Celgene)
    Peter Szitanyi, Prague, Czech Republic (Charles University)
    William Treem, Cambridge, United States (Takeda)
    17:05-17:55 5: Session 4: EMA recommendations for clinical trial design in IBD
    Mark Ainsworth, Copenhagen, Denmark (Danish Medicines Agency)

    Panel discussion and interaction with the audience:
    Mark Ainsworth, Copenhagen, Denmark
    John Mansfield, Newcastle Upon Tyne, United Kingdom
    Julián Panés, Barcelona, Spain

    Wulf Böcher, Ingelheim, Germany (Boehringer Ingelheim)
    Freddy Cornillie, Kriens, Switzerland (MSD International)
    17:55-18:00 6: Closing remarks
    Krisztina Gecse, Amsterdam, The Netherlands